Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology drug discovery, has announced the appointment of a new chief business officer. The company has named veteran Pamela Bush to the role. Bush was featured during a recent Proactive video release, during which she and host Natalie Stoberman discussed her new assignment. During the interview, Bush explained that she will be overseeing all business development, partnering and growth strategies for Predictive Oncology; she will also be managing the company’s strategic, operational and financial planning initiatives for existing customers as well as emerging new markets. Bush bring an impressive track record to her new role. She has been with POAI and served as senior vice president of strategic sales and business development at the company; in that position, she was instrumental in guiding the company’s strategic direction as well as expanding product offerings and launching commercialization development for Predictive Oncology’s flagship technology platform.

To view the full press release, visit https://ibn.fm/d03Sh

About Predictive Oncology Inc.

Predictive Oncology, a science-driven company on the leading edge of oncology drug discovery, offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of more than 150,000 tumor samples. Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork